CURRENT

At a pharmaceutical company, compliance reports that took analysts three days started drafting overnight. Productivity soared. Then engagement scores dropped, and nobody could explain it, because nothing in the dashboard measured what those three days had actually been building. That gap kept surfacing as we put this issue together. Governance tooling that sends agents to production twelve times faster, for instance, governs what's auditable. Whether it governs what matters is a different question, and almost nobody is asking it yet. Every section landed somewhere similar. What we've learned to measure looks fine. The costs are accumulating where we haven't thought to look.